Factors influencing familial decision-making regarding human papillomavirus vaccination

Journal of Pediatric Psychology

Volumn 35, Issue 7, 2010, Pages 704-715

  Gamble, Heather L ^a,b   Klosky, James L ^a   Parra, Gilbert R ^b   Randolph, Mary E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b University of Memphis   (United States)

Author keywords

cancer and oncology; health promotion and prevention; parent adolescent communication; sexually transmitted diseases

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; DECISION MAKING; FAMILY; FEMALE; HUMAN; IMMUNOLOGY; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; REVIEW; VACCINATION;

ADOLESCENT; CHILD; DECISION MAKING; FAMILY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION;

EID: 77955041546     PISSN: 01468693     EISSN: 1465735X     Source Type: Journal    
DOI: 10.1093/jpepsy/jsp108     Document Type: Article

References (98)

1. American Academy of Pediatrics Section on Hematology/ Oncology Children's Oncology Group. (2009). Long- term follow-up care for pediatric cancer survivors. Pediatrics, 123, 906-915.
2. American Cancer Society. (2008a). Cancer facts & figures 2008. Atlanta: Author.
3. American Cancer Society. (2008b). What causes cancer of the cervix? Retrieved July 2, 2009, from http://www.cancer.org/docroot/CRI/content/CRI-2- 2-2X-What-causes-cancer-of-the-cervix-Can-it- be-prevented-8.asp?rnav=cri.
4. Association of Reproductive Health Professionals. (2005). Cervical cancer prevention and HPV DNA testing: Targeting high-risk virus types. Health and Sexuality, 10, 2-5.
5. Ault, K. A. (2007). Long-term efficacy of human papillomavirus vaccination. Gynecologic Oncology, 107, 27-30.
6. Bosch, F. X., & de Sanjose, S. (2003). Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. Journal of the National Cancer Institute Monographs, 31 , 3-13.
7. Brabin, L., Roberts, S. A., Farzaneh, F., & Kitchener, H. C. (2006). Future acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes. Vaccine, 24, 3087-3094.
8. Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45, 107-114.
9. Burchell, A. N., Winer, R. L., de Sanjose, S., & Franco, E. L. (2006). Chapter 6: Epidemiology and transmission dynamics of genital genital HPV infection. Vaccine, 24, 5261.
10. Centers for Disease Control and Prevention. (2007a). Fast facts that address statements made in a press release by the National Vaccine Information Center on 08/15/07 regarding Gardasil and Guillain-Barre Syndrome.
11. Centers for Disease Control and Prevention. (2007b). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 56, 1-26.
12. Centers for Disease Control and Prevention. (2008). Vaccination coverage among adolescents aged 13-17 years-United States, 2007. Morbidity and Mortality Weekly Report, 57, 1100-1103.
13. Chao, C., Slezak, J., Coleman, K., &Jacobsen, S. (2009). Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. American Journal of Public Health, 99, 1137-1142.
14. Committee on Bioethics. (1995). Informed consent, parental permission, and assent in pediatric practice. Pediatrics, 95, 314-317.
15. Constantine, N. A., &Jerman, P. (2007). Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. Journal of Adolescent Health, 40, 108-115.
16. Courtney, A. E., Leonard, N., O'Neill, C. J., McNamee, P. T., & Maxwell, A. P. (2009). The uptake of cervical cancer screening by renal transplant recipients. Nephrology Dialysis Transplantation, 24, 647-652.
17. D'Souza, G., Agrawal, Y., Halpern, J., Bodison, S., & Gillison, M. L. (2009). Oral sexual behaviors associated with prevalent oral human papillomavirus infection. Journal of Infectious Diseases, 199, 1263-1269.
18. Daley, M. F., Liddon, N., Crane, L. A., Beaty, B. L., Barrow, J., Babbel, C., et al. (2006). A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118, 2280-2289.
19. de Visser, R., & McDonnell, E. (2008). Correlates of parents' reports of acceptability of human papilloma virus vaccination for their school-aged children. Sexual Health, 5, 331-338.
20. Dell, D. L., Chen, H., Ahmad, F., & Stewart, D. E. (2000). Knowledge about human papillomavirus among adolescents. Obstetrics & Gynecology, 96, 653-656.
21. Dempsey, A. F., Abraham, L. M., Dalton, V., & Ruffin, M. (2009). Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Annals of Epidemiology, 19, 531-538.
22. Di Stefano, L., Coppola, G., Moro, S., Colageo, E., Cellini, A., & Coletti, G. (2006). Cervical-vaginal disease in HIV immunosuppressed patients: Management and present screening programme. European Journal of Gynaecological Oncology, 27, 267-270.
23. Diamond, C., & Buskin, S. (2000). Continued risky behavior in HIV-infected youth. American Journal of Public Health, 90, 115-118.
24. Dunne, E. F., Datta, S. D., & Markowitz, L. E. (2008). A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer, 113, 2995-3003.
25. Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., et al. (2007). Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297, 813-819.
26. Eaton, D. K., Kann, L., Kinchen, S., Shanklin, S., Ross, J., Hawkins, J., et al. (2008). Youth risk behavior surveillance-United States, 2007. Morbidity and Mortality Weekly Report Surveillance Summaries, 57, 1-131.
27. Eisenberg, M. E., Sieving, R. E., Bearinger, L. H., Swain, C., & Resnick, M. D. (2006). Parents' communication with adolescents about sexual behavior: A missed opportunity for prevention? Journal of Youth and Adolescence, 35, 893-902.
28. Epstein, R. J. (2005). Primary prevention of human papil- lomavirus-dependent neoplasia: No condom, no sex. European Journal of Cancer, 41 , 2595-2600.
29. FDA. (2006b). HPV (human papillomavirus). Retrieved June 18, 2008, from http://www.fda.gov/womens/ getthefacts/hpv.html.
30. Flory, K., Molina, B. S. G., Pelham, W. E. Jr., Gnagy, E., & Smith, B. (2006). Childhood ADHD predicts risky sexual behavior in young adulthood. Journal of Clinical Child and Adolescent Psychology, 35, 571-577.
31. Gerend, M. A., Lee, S. C., & Shepherd, J. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34, 468-471.
32. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., et al. (2000). Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute, 92, 709-720.
33. Gillison, M. L., & Shah, K. V. (2001). Human papilloma- virus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Current Opinion in Oncology, 13, 183-188.
34. Giuliano, A. R., Lazcano-Ponce, E., Villa, L., Nolan, T., Marchant, C., Radley, D., et al. (2007). Impact of baseline covariates on the immunogenicity of a quadrivalent (Types 6, 11, 16, and 18) human papil- lomavirus virus-like-particle vaccine. The Journal of Infectious Diseases, 196, 1153-1162.
35. Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., et al. (2004). Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of the National Cancer Institute, 96, 604-615.
36. Hagensee, M. E., Cameron, J. E., Leigh, J. E., & Clark, R.(2004). Human papillomavirus infection and disease in HIV-infected individuals. American Journal of the Medical Sciences, 328, 57-63.
37. Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A. , Romanowski, B., Roteli-Martins, C. M., et al. (2006). Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillo- mavirus types 16 and 18: Follow-up from a randomised control trial. Lancet, 367, 1247-1255.
38. Harper, D. M., & Paavonen, J. (2008). Age for HPV vaccination. Vaccine, 26, A7-A11.
39. Hennessey, P. T., Westra, W. H., & Califano, J. A. (2009). Human papillomavirus and head and neck squamous cell carcinoma: Recent evidence and clinical implications. Journal of Dental Research, 88, 300-306.
40. Hoover, D. R., Carfioli, B., & Moench, E. A. (2000). Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care for Women International, 21, 375-391.
41. Jaccard, J., & Dittus, P. J. (2000). Adolescent perceptions of maternal approval of birth control and sexual risk behavior. American Journal of Public Health, 90, 1426-1430.
42. Jaccard, J., Dittus, P. J., & Litardo, H. A. (1999). Parent- adolescent communication about sex and birth control: Implications for parent-based interventions to reduce unintended adolescent pregnancy. In W. Miller, & L. J. Severy (Eds.), Advances in population: Psychosocial perspectives (pp. 220-246). London: Jessica Kingsley Publishers.
43. Kahn, J. A., Rosenthal, S. L., Hamann, T., & Bernstein, D. I. (2003). Attitudes about human papillomavirus vaccine in young women. International Journal of STD &AIDS, 14, 300-306.
44. Kahn, J. A., Rosenthal, S. L., Jin, Y., Huang, B., Namakydoust, A., Rosemore, J., et al. (2008). 32: Vaccine-type HPV infection and post-licensure attitudes about HPV vaccination in young women. Journal of Adolescent Health, 42, 28-29.
45. Kahn, J. A., Rosenthal, S. L., Jin, Y., Huang, B., Namakydoust, A., & Zimet, G. D. (2008). Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetrics & Gynecology, 111 , 1103-1110.
46. Kahn, J. A., Rosenthal, S. L., Tissot, A. M., Bernstein, D. I., Wetzel, C., & Zimet, G. D. (2007). Factors influencing pediatricians' intention to recommend human papil- lomavirus vaccines. Ambulatory Pediatrics, 7, 367-373.
47. Kahn, J. A., Zimet, G. D., Bernstein, D. I., Riedesel, J. M., Lan, D., Huang, B., et al. (2005). Pediatricians intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health, 37, 502510.
48. Keane, V., Stanton, B., Horton, L., Aronson, R., Galbraith, J., & Hughart, N. (1993). Perceptions of vaccine efficacy, illness, and health among inner-city parents. Clinical Pediatrics, 32, 2-7.
49. Kirby, D., & Coyle, K. (1997). School-based programs to reduce sexual risk taking behavior. Children and Youth Services Review, 19, 415-436.
50. Klosky, J. L., Gamble, H. L., Spunt, S. L.,Randolph-Frye, M., Green, D., & Hudson, M. M. (2009). Human papillomavirus (HPV) vaccination in survivors of childhood cancer. Cancer, 26, 287-295.
51. Koutsky, L. A., & Harper, D. M. (2006). Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine, 24, 114-121.
52. Lefkowitz, E. S., Boone, T. L., Au, T. K., & Sigman, M. (2003). No sex or safe sex? Mothers' and adolescents' discussions about sexuality and AIDS/HIV. Health Education Research, 18, 341-351.
53. Mariam, A. (2005). Cervical cancer vaccines available in 2007. Drug Discovery Today, 10, 949-950.
54. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report Recommendations and Reports, 56, 1-24.
55. Marlow, L. A., Forster, A. S., Wardle, J., & Waller, J. (2009). Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. Journal of Adolescent Health, 44, 446-451.
56. Marlow, L. A., Waller, J., & Wardle, J. (2007a). Parental attitudes to pre-pubertal HPV vaccination. Vaccine, 25, 1945-1952.
57. Marlow, L. A., Waller, J., & Wardle, J. (2007b). Trust and experience as predictors of HPV vaccine acceptance. Human Vaccines, 3, 171-175.
58. Mays, R. M., Sturm, L. A., & Zimet, G. D. (2004). Parental perspectives on vaccinating children against sexually transmitted infections. Social Science & Medicine, 58, 1405-1413.
59. Mays, R. M., Zimet, G. D., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Human papillomavirus, genital warts, Pap smears, and cervical cancer: Knowledge and beliefs of adolescent and adult women. Health Care for Women International, 21 , 361-374.
60. McNeely, C., Shew, M. L., Beuhring, T., Sieving, R., Miller, B. C., & Blum, R. W. (2002). Mothers' influence on the timing of first sex among 14- and 15-year-olds. Journal of Adolescent Health, 31 , 256-265.
61. Miller, K. S., Kotchick, B. A., Dorsey, S., Forehand, R., & Ham, A. Y. (1998). Family communication about sex: What are parents saying and are their adolescents listening? Family Planning Perspectives, 30, 218-222, 235.
62. Miller, K. S., Levin, M. L., Whitaker, D. J., &Xu, X. (1998). Patterns of condom use among adolescents: The impact of mother-adolescent communication. American Journal of Public Health, 88, 1542-1544.
63. Moleski, M. (2000). Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology, 15, 603-630.
64. Mosavel, M., & El-Shaarawi, N. (2007). ''I have never heard that one'': Young girls' knowledge and perception of cervical cancer. Journal of Health Communication, 12, 707-719.
65. Mulhern, R. K., Fairclough, D., & Ochs, J. (1991). A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. Journal of Clinical Oncology, 9, 1348-1356.
66. National Cancer Institute. (2007). National Cancer Institute fact sheet 5.16. Retrieved July 7, 2008, from http://www.cancer.gov/cancertopics/factsheet/ detection/Pap-test.
67. Olshen, E., Woods, E. R., Austin, S. B., Luskin, M., & Bauchner, H. (2005). Parental acceptance of the human papillomavirus vaccine. Journal of Adolescent Health, 37, 248-251.
68. Paavonen, J., & Lehtinen, M. (2008). Introducing human papillomav vaccines - Questions remain. Annals of Internal Medicine, 40, 162166.
69. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. Cancer, 55, 74-108.
70. Ragin, C., Edwards, R., Jones, J., Thurman, N., Hagan, K., Jones, E., et al. (2009). Knowledge about human papillomavirus and the HPV vaccine - a survey of the general population. Infectious Agents and Cancer, 4, S10.
71. Rose, B., Wilkins, D., Li, W., Tran, N., Thompson, C., Cossart, Y., et al. (2006). Human papillomavirus in the oral cavity of patients with and without renal transplantation. Transplantation, 82, 570-573.
72. Rosenthal, S. L., Kottenhahn, R. K., Biro, F. M., & Succop, P. A. (1995). Hepatitis B vaccine acceptance among adolescents and their parents. Journal of Adolescent Health, 17, 248-254.
73. Rosenthal, S. L., Rupp, R., Zimet, G. D., Meza, H. M., Loza, M. L., Short, M. B., et al. (2008). Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health, 43 , 239-245.
74. Sanders, G. D., & Taira, A. V. (2003). Cost-effectiveness of a potential vaccine for human papillomavirus. Emerging Infectious Diseases, 9, 37-48.
75. Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., et al. (2007). American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians, 57, 7-28.
76. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. (2006). Retrieved July 9, 2008, from http://seer.cancer.gov/csr/1975-2005/.
77. Sirivongrangson, P., Bollen, L. J., Chaovavanich, A., Suksripanich, O., Virapat, P., Tunthanathip, P., et al. (2007). Screening HIV-infected women for cervical cancer in Thailand: Findings from a demonstration project. Sexually Transmitted Diseases, 34, 104-107.
78. Slomovitz, B. M., Sun, C. C., Frumovitz, M., Soliman, P. T., Schmeler, K. M., Pearson, H. C., et al (2006). Are women ready for the HPV vaccine? Gynecologic Oncology, 103, 151-154.
79. Smith, R., Malee, K., Leighty, R., Brouwers, P., Mellins, C. Hittelman, J., et al. (2006). Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics, 117, 851-862.
80. Sturm, L. A., Mays, R. M., & Zimet, G. D. (2005). Parenta beliefs and decision making about child and adolescent immunization: From polio to sexually transmitted infections. Journal of Developmental & Behavioral Pediatrics, 26, 441-452.
81. Swain, C. R., Ackerman, L. K., & Ackerman, M. A. (2006) The influence of individual characteristics and contraceptive beliefs on parent-teen sexual communi cations: A structural model. Journal of Adolescent Health, 38, 753.e759-753.e718.
82. Vanable, P., Carey, M. P., Brown, J. L., Bostwick, R. A., & Kraus, C. R. (2009). HPV Vaccination among African American adolescent girls: Prevalence, correlates, and psychosocial barriers. Paper presented at the Society o Behavioral Medicine 30th Annual Meeting & Scientific Sessions, Montreal, Quebec.
83. Villa, L. L. (2007). Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18 vaccine. International Journal of Infectious Diseases, 11 S17-S25.
84. Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., et al. (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women A randomised double-blind placebo-controlled multi- centre phase II efficacy trial. Lancet Oncology, 6, 271-278.
85. Waggoner, S. E. (2003). Cervical cancer. The Lancet, 361 , 2217-2225.
86. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12-19.
87. Weinstock, H., Berman, S., & Cates, W. Jr. (2004). Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproduct
88. Whitaker, D. J., Miller, K. S., May, D. C., & Levin, M. L. (1999). Teenage partners' communication about sexual risk and condom use: The importance of parent-teenager discussions. Family Planning Perspectives, 31, 117-121.
89. Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women. New England Journal of Medicine, 354, 2645-2654.
90. Wulf, D. (2002). In their own right: Addressing the sexual and reproductive health needs of American men. New York: Alan Guttmacher Institute.
91. Yeazel, M. W., Oeffinger, K. C., Gurney, J. G., Mertens, A. C., Hudson, M. M., Emmons, K. M., et al. (2004). The cancer screening practices of adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer, 100, 631-640.
92. Zebrack, B. J., Casillas, J., Nohr, L., Adams, H., & Zeltzer, L. K. (2004). Fertility issues for young adult survivors of childhood cancer. Psychooncology, 13, 689-699.
93. Zimet, G. D., Blythe, M. J., & Fortenberry, J. D. (2000). Vaccine characteristics and acceptability of HIV immunization among adolescents. International Journal of STD & AIDS, 11, 143-149.
94. Zimet, G. D., Fortenberry, J. D., & Blythe, M. J. (1999). Adolescents' attitudes about HIV immunization. Journal of Pediatric Psychology, 24, 67-75.
95. Zimet, G. D., Liddon, N., Rosenthal, S. L., Lazcano-Ponce, E., & Allen, B. (2006). Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine, 24, 201-209.
96. Zimet, G. D., Mays, R. M., & Fortenberry, J. D. (2000). Vaccines against sexually transmitted infections: Promise and problems of the magic bullets for prevention and control. Sexually Transmitted Diseases, 27, 49-52.
97. Zimet, G. D., Mays, R. M., Winston, Y., Kee, R., Dickes, J., & Su, L. (2000). Acceptability of human papilloma- virus immunization. Journal of Women's Health and Gender-Based Medicine, 9, 47-50.
98. Ziv, A., Boulet, J. R., & Slap, G. B. (1999). Utilization of physician offices by adolescents in the United States. Pediatrics, 104, 35-42.